Evidence map›Paper›PMID 42495119›Full record

ArticleFrontiers in bioengineering and biotechnology2026

Comparative evaluation of YOLOv8, YOLOv11, and RT-DETR for automated microcarrier colonization assessment in bioreactor cell cultures.

Manuel T Fernández de Sevilla, Raúl Valero, Beatriz Menéndez, Gonzalo García Domínguez, Cristina Blanco Sánchez, Natalia Canales, Ramón Menta Hernández, Marta H G Costa, Margarida Serra, Eleuterio Lombardo and 2 more

Abstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Manuel T Fernández de Sevilla *Cell Therapies Science Department, Takeda Madrid Cell Therapy Technology Center, Madrid, Spain.
Raúl Valero *Cell Therapies Science Department, Takeda Madrid Cell Therapy Technology Center, Madrid, Spain.
Beatriz Menéndez *Cell Therapies Science Department, Takeda Madrid Cell Therapy Technology Center, Madrid, Spain.
Gonzalo García Domínguez *Cell Therapies Science Department, Takeda Madrid Cell Therapy Technology Center, Madrid, Spain.
Cristina Blanco Sánchez *Cell Therapies Science Department, Takeda Madrid Cell Therapy Technology Center, Madrid, Spain.
Natalia Canales *Cell Therapies Science Department, Takeda Madrid Cell Therapy Technology Center, Madrid, Spain.
Ramón Menta HernándezCell Therapies Science Department, Takeda Madrid Cell Therapy Technology Center, Madrid, Spain.
Marta H G CostaiBET - Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal.
Margarida SerraiBET - Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal.
Eleuterio LombardoCell Therapies Science Department, Takeda Madrid Cell Therapy Technology Center, Madrid, Spain.
Alvaro Avivar-Valderas *Cell Therapies Science Department, Takeda Madrid Cell Therapy Technology Center, Madrid, Spain.
Pablo Mancheño-Corvo *Cell Therapies Science Department, Takeda Madrid Cell Therapy Technology Center, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Monitoring microcarrier colonization during mesenchymal stromal cell (MSC) expansion in bioreactors is essential for process control. Current manual quantification methods are time-consuming, subjective, and prone to inter-operator variability. This study presents a proof-of-concept evaluation of deep learning-based object detection for automated microcarrier colonization quantification in bioreactor cell cultures. Methods: Three state-of-the-art architectures-YOLOv8, YOLOv11, and RT-DETR-were compared within a unified experimental framework. A dataset of 699 fluorescence microscopy images containing 46,982 annotated microcarriers (classified as colonized or non-colonized) was used for training and evaluation. Model selection followed a three-stage Successive Halving Algorithm (SHA) strategy to efficiently identify the best-performing architecture across 12 configurations without requiring high-end computational infrastructure. COCO-pretrained transfer learning was applied across all models. Results: YOLOv8-l emerged as the top-performing model, achieving mAP50-95 of 0.855 on validation and 0.787 on test, with a colonization estimation error (Mean Absolute Error) of 11.75%. The dataset size proved sufficient for CNN-based architectures, while also revealing the higher data demands of transformer-based detectors. Discussion: These results demonstrate that automated deep learning pipelines can reliably quantify microcarrier colonization, offering a practical alternative to manual assessment in cell therapy manufacturing. The findings also suggest that newer YOLO models do not necessarily yield improvements in domain-specific biomedical tasks.

Indexed as

bioreactorscell therapycolonizationcomputer visionin-process controlmesenchymal stromal cellYOLO

Identifiers

PMID42495119
PMCPMC13391946

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.